Distinct Urea Cycle Dysfunction Profiles Differentiate Acute Metabolic Decompensation in TMEM70 and MT ‐ ATP6 ‐Related Mitochondrial ATP Synthase Defects
- 10 September 2026
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (5)
Abstract
ATP synthase defects, including TMEM70 and MT‐ATP6 deficiencies, cause severe mitochondrial encephalo‐(cardio)‐myopathies complicated by acute metabolic decompensations (AMDs) often associated with hyperammonaemia. However, detailed biochemical characterisation of these events remains limited. The aim of the study was to evaluate the metabolic profiles associated with TMEM70 and MT‐ATP6 deficiencies during AMDs in comparison to stable metabolic conditions, assessing frequency and severity of hyperammonaemia, and exploring the mechanisms linking impaired mitochondrial ATP production to the urea cycle by in vivo ureagenesis studies, using [ 15 N] ammonium chloride as stable isotope and assessed by high‐resolution mass‐spectrometry coupled with liquid chromatography. We retrospectively analysed clinical and biochemical profiles from two genetically confirmed cohorts. Patients with TMEM70 deficiency experienced more frequent AMDs, often with hyperammonaemia and requiring extracorporeal detoxification, while the MT‐ATP6 cohort had more prominent neurological symptoms and a lower incidence of hyperammonaemia. Biochemically, both groups showed elevated lactate, alanine and glutamine, with orotic aciduria and abnormalities in purine/pyrimidine metabolism. Plasma citrulline levels were divergent in the two cohorts, with a consistent reduction in patients with MT‐ATP6 deficiency and normal or borderline elevated levels in the TMEM70 cohort. In vivo stable isotope studies pointed to the differential impact of TMEM70 and MT‐ATP6 deficiency on ureagenesis and on the enrichment of individual urea cycle‐related amino acids. This study reveals that TMEM70 and MT‐ATP6 deficiencies share features of mitochondrial dysfunction but present distinct metabolic profiles, highlighting a different impact on the urea cycle and its related metabolites, and providing novel insights on our understanding of mitochondrial pathophysiology.Keywords
Funding Information
- Ministero della Salute
- Citrin Foundation (RG24003)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_207965)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII‐222794)
This publication has 35 references indexed in Scilit:
- Quo vadis ureagenesis disorders? A journey from 90 years ago into the futureJournal of Inherited Metabolic Disease, 2024
- MT‐ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotypeAmerican Journal of Medical Genetics Part A, 2023
- A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated familiesJournal of Inherited Metabolic Disease, 2022
- Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemiaJournal of Inherited Metabolic Disease, 2020
- Delayed appearance of 3‐methylglutaconic aciduria in neonates with early onset metabolic cardiomyopathies: A potential pitfall for the diagnosisAmerican Journal of Medical Genetics Part A, 2019
- Suggested guidelines for the diagnosis and management of urea cycle disorders: First revisionJournal of Inherited Metabolic Disease, 2019
- TMEM70 deficiency: Novel mutation and hypercitrullinemia during metabolic decompensationAmerican Journal of Medical Genetics Part A, 2019
- Mitochondrial complex deficiency by novel compound heterozygous
TMEM
70
variants and correlation with developmental delay, undescended testicle, and left ventricular noncompaction in a Japanese patient: A case reportClinical Case Reports, 2019
- Metabolism of citrulline in manAmino Acids, 1995
- Allopurinol challenge test in childrenJournal of Inherited Metabolic Disease, 1991